» Authors » M Hertl

M Hertl

Explore the profile of M Hertl including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 189
Citations 2329
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Maglie R, Hertl M
Br J Dermatol . 2019 Sep; 182(3):539-540. PMID: 31494928
No abstract available.
12.
Kapp F, Reinholz M, Wollenberg A, Jakob T, Hertl M, Wolf R, et al.
Hautarzt . 2018 Nov; 70(1):76-78. PMID: 30397746
No abstract available.
13.
Maglie R, Hertl M
J Eur Acad Dermatol Venereol . 2018 Oct; 32(10):1623-1624. PMID: 30303304
No abstract available.
14.
Solimani F, Pollmann R, Ishii N, Eming R, Hashimoto T, Schmidt T, et al.
J Eur Acad Dermatol Venereol . 2018 Jul; 33(4):735-741. PMID: 29972879
Background: Anti-laminin-γ1 (lam-γ1) pemphigoid, a recently described immunobullous disorder sharing immune serological features of bullous pemphigoid and epidermolysis bullosa acquisita (EBA), is characterized by the detection of serum IgG autoantibodies...
15.
16.
Prost-Squarcioni C, Caux F, Schmidt E, Jonkman M, Vassileva S, Kim S, et al.
Br J Dermatol . 2017 Nov; 179(1):30-41. PMID: 29165796
Background: Epidermolysis bullosa acquisita (EBA) is a complex autoimmune bullous disease disease with variable clinical presentations and multiple possible diagnostic tests, making an international consensus on the diagnosis of EBA...
17.
Schmidt T, Hoch M, Lotfi Jad S, Solimani F, Di Zenzo G, Marzano A, et al.
Br J Dermatol . 2017 Jul; 177(6):1683-1692. PMID: 28703393
Background: Epidermolysis bullosa acquisita (EBA) is a rare, potentially devastating autoimmune disease of the skin. IgG autoantibodies directed against type VII collagen (Col7), the major component of anchoring fibrils, induce...
18.
Sticherling M, Franke A, Aberer E, Glaser R, Hertl M, Pfeiffer C, et al.
Br J Dermatol . 2017 May; 177(5):1299-1305. PMID: 28494097
Background: Current treatment of bullous pemphigoid (BP) is based on the long-term use of topical and/or systemic corticosteroids, which are associated with a high rate of adverse events and increased...
19.
Shah J, Patel M, Elias N, Navarro-Alvarez N, Rosales I, Wilkinson R, et al.
Am J Transplant . 2017 May; 17(8):2178-2185. PMID: 28489305
Since the first attempt of pig-to-primate liver xenotransplantation (LXT) in 1968, survival has been limited. We evaluated a model utilizing α-1,3-galactosyltransferase knockout donors, continuous posttransplant infusion of human prothrombin concentrate...
20.
Zimmerman A, Flahive J, Hertl M, Cosimi A, Saidi R
Int J Organ Transplant Med . 2017 Apr; 7(2):69-76. PMID: 28435638
Background: Splitting a liver for utilization in adult/pediatric recipients has been shown to decrease mortality on the wait list without increasing the overall risk of long-term graft failure compared to...